ID
35667
Description
Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer
Keywords
Versions (1)
- 3/14/19 3/14/19 -
Copyright Holder
GSK group of companies
Uploaded on
March 14, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369
Treatment Completion Form
- StudyEvent: ODM
Description
Treatment Completion
Description
Total number of courses
Data type
integer
Description
check only one
Data type
text
Description
Specify Other
Data type
text
Description
plans for further therapy
Data type
text
Description
Tumor Measurements
Data type
integer
Measurement units
- cm
Description
Tumor Measurements
Description
Best Tumor Response
Description
Follow-Up Form
Description
Lost to follow-up
Data type
boolean
Description
Vital Status
Data type
text
Description
Date of last contact
Data type
date
Description
Death reason
Data type
text
Description
Disease Follow-Up Status
Description
Disease Follow-Up Status
Data type
text
Description
date of assessment
Data type
date
Description
disease progression/recurrence
Data type
boolean
Description
Progression/recurrence date
Data type
date
Description
Determination method
Data type
integer
Description
Site / Marker
Data type
text
Description
location of progression
Data type
boolean
Description
Notice of New Primary
Description
Long Term Adverse Events
Description
Adverse Events details
Description
Additional Cancer Therapy
Similar models
Treatment Completion Form
- StudyEvent: ODM